NCT00634556View on ClinicalTrials.gov

Dopaminergic Effects on Cortical Function in Tourette's (Levodopa Protocol)

PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Tourette Syndrome
Interventions
DRUG

levodopa solution 2mg/ml for i.v. use

2mg/mL in normal saline

DRUG

placebo

normal saline

Trial Locations (1)

63110

Washington Universisty School of Medicine,, St Louis

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Washington University School of Medicine

OTHER

NCT00634556 - Dopaminergic Effects on Cortical Function in Tourette's (Levodopa Protocol) | Biotech Hunter | Biotech Hunter